Specops Medical Supply, LLC

Specops Medical Supply, LLC, a Service-Disabled Veteran-Owned Small Business headquartered in McKinney, Texas, manufactures and supplies neuromuscular stimulation devices, prosthetics, orthotic equipment, and vein visualization systems to the Department of Veterans Affairs as a prime contractor, operating predominantly under full-and-open competition on the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A) with no subcontract activity.

Specops holds a $157.2 million Federal Supply Schedule contract through May 31, 2031, awarded June 1, 2026, under which the VA places delivery orders for L300 GO Systems (functional electrical stimulation devices), Bioness neuromuscular stimulation equipment, vein viewers, custom prosthetics and orthotics, bone stimulators, and surgical implants. Representative recent delivery orders include a $41,863.20 award from VISN 6 for L300 GO Systems (ultimate completion August 30, 2026), a $49,856.02 award from VISN 8 for electrical stimulation rehabilitation systems (September 29, 2027), a $62,752.96 award from VISN 16 for a Bioness Therapy System (August 27, 2027), and a $42,714.92 SDVOSB set-aside purchase order from VISN 22 for a Functional Electrical Stimulator System (July 4, 2025). Specops also holds two smaller indefinite delivery contracts—one with VA Headquarters valued at approximately $8.3 million for vein finders and related medical equipment, and another $326 thousand SDVOSB set-aside vehicle with VISN 17 for ultrasound coronary catheters.

Customer concentration is extreme and skewed heavily toward the VA Veterans Health Administration. The top five VA VISNs (8, 17, 6, 7, and 10) account for 47 percent of awards by count but only a small fraction of dollars; however, VISN 12 anchors the portfolio with 33 awards and $160 million in combined potential value—a stark divergence reflecting a single large multi-year supply agreement. VA Headquarters contributes an additional $9.1 million across 9 awards. The VA as a whole represents the overwhelming majority of Specops' federal footprint; the vendor also transacts with 23 distinct customer agencies but concentrates nearly all revenue in the Veterans Health Administration across multiple regional networks.

Award activity has grown significantly. The vendor executed 69 awards in 2022, 134 in 2023, 155 in 2024, and 139 in 2025. As of October 1, 2026, only 23 awards have been recorded for the current year, reflecting the recency of source data capture; the vendor's typical annual volume runs 130–160 awards. Combined potential value across the 874 prime awards in the source is $193.7 million, with $25.7 million (13 percent) obligated to date. Seventeen awards with ultimate completion dates in the next twenty-four months carry combined potential value of $1.4 million and represent modest recompete exposure.

The Medical Equipment and Supplies FSS vehicle carries 441 task orders valued at $7.9 million and dominates the parent vehicle footprint. Two smaller indefinite delivery contracts—36C25719D0060 (13 task orders, $148 thousand) and 36C10G22D0005 (8 task orders, $794 thousand)—supplement the primary schedule. The FSS vehicle operates as a multi-agency ordering mechanism; agencies place orders against Specops' published price list without running new competitions, explaining the high task-order volume relative to potential value.

Specops manufactures across three primary NAICS categories: Surgical Appliance and Supplies Manufacturing (587 awards), Surgical and Medical Instrument Manufacturing (126 awards), and Electromedical and Electrotherapeutic Apparatus Manufacturing (105 awards). PSC coding reflects Medical and Surgical Instruments, Equipment, and Supplies (797 awards), with secondary codes for Imaging Equipment and Hospital Furniture. The company operates as a sole proprietorship limited liability company and holds dual SBA certifications as both a Veteran-Owned Small Business and Service-Disabled Veteran-Owned Small Business through October 25, 2027; approximately 20 percent of recent awards explicitly cite SDVOSB set-asides, though the vendor competes predominantly in full-and-open procurements where SDVOSB status provides market advantage rather than a set-aside guarantee. Specops carries no subcontract relationships and operates exclusively as a prime supplier to federal healthcare agencies.